• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

腹膜间皮瘤的当前治疗策略。

Current management strategies for peritoneal mesothelioma.

机构信息

a Department of Surgery , University of Chicago , Chicago , IL , USA.

b Fondazione IRCCS Istituto Nazionale Tumori Milano , Milano , Italy.

出版信息

Int J Hyperthermia. 2017 Aug;33(5):579-581. doi: 10.1080/02656736.2017.1320591.

DOI:10.1080/02656736.2017.1320591
PMID:28664790
Abstract

Mesothelioma of the peritoneum is a distinct entity that requires multidisciplinary care to improve oncological outcomes. In this article, we review the current management strategies discussed at the PSOGI meeting in Washington DC 2016 and provide evidence based recommendations for diagnosis and management of this disease.

摘要

腹膜间皮瘤是一种独特的实体瘤，需要多学科的护理来改善肿瘤学的结果。在本文中，我们回顾了 2016 年在华盛顿特区举行的 PSOGI 会议上讨论的当前管理策略，并为该疾病的诊断和管理提供了基于证据的建议。

相似文献

1
Current management strategies for peritoneal mesothelioma.腹膜间皮瘤的当前治疗策略。
Int J Hyperthermia. 2017 Aug;33(5):579-581. doi: 10.1080/02656736.2017.1320591.
2
Drugs, doses, and durations of intraperitoneal chemotherapy: standardising HIPEC and EPIC for colorectal, appendiceal, gastric, ovarian peritoneal surface malignancies and peritoneal mesothelioma.腹腔内化疗的药物、剂量和时间：结直肠、阑尾、胃、卵巢腹膜表面恶性肿瘤和腹膜间皮瘤的 HIPEC 和 EPIC 标准化。
Int J Hyperthermia. 2017 Aug;33(5):582-592. doi: 10.1080/02656736.2017.1291999.
3
Five reasons why cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy must be regarded as the new standard of care for diffuse malignant peritoneal mesotheliomia [corrected].
Ann Surg Oncol. 2010 Jun;17(6):1710-2; author reply 1713-4. doi: 10.1245/s10434-010-1042-z.
4
Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC).弥漫性恶性腹膜间皮瘤：完全细胞减灭术联合腹腔内热灌注化疗（HIPEC）的长期生存。
Eur J Cancer. 2013 Oct;49(15):3140-8. doi: 10.1016/j.ejca.2013.05.027. Epub 2013 Jul 4.
5
Multicystic peritoneal mesothelioma: outcomes and patho-biological features in a multi-institutional series treated by cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).多囊性腹膜间皮瘤：接受细胞减灭术和腹腔热灌注化疗（HIPEC）治疗的多机构系列的结果和病理生物学特征。
Eur J Surg Oncol. 2010 Nov;36(11):1047-53. doi: 10.1016/j.ejso.2010.08.130. Epub 2010 Sep 15.
6
Hyperthermia: has its time come?热疗：时机已到？
Ann Surg Oncol. 2003 Apr;10(3):210-2. doi: 10.1245/aso.2003.02.011.
7
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience.细胞减灭术和腹腔内热灌注化疗治疗恶性腹膜间皮瘤：多机构经验。
J Clin Oncol. 2009 Dec 20;27(36):6237-42. doi: 10.1200/JCO.2009.23.9640. Epub 2009 Nov 16.
8
Cytoreductive surgery with selective versus complete parietal peritonectomy followed by hyperthermic intraperitoneal chemotherapy in patients with diffuse malignant peritoneal mesothelioma: a controlled study.细胞减灭术联合选择性或完全腹膜切除术与腹腔内热灌注化疗治疗弥漫性恶性腹膜间皮瘤的对照研究。
Ann Surg Oncol. 2012 May;19(5):1416-24. doi: 10.1245/s10434-012-2237-2.
9
Complete pathological response to neoadjuvant pemetrexed/cisplatin in combination with regional hyperthermia in a patient with sarcomatoid peritoneal mesothelioma.一名肉瘤样腹膜间皮瘤患者对新辅助培美曲塞/顺铂联合区域热疗产生完全病理反应。
Anticancer Drugs. 2014 Aug;25(7):854-6. doi: 10.1097/CAD.0000000000000106.
10
Combined laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a patient with peritoneal mesothelioma.腹腔镜减瘤手术联合腹腔热灌注化疗治疗腹膜间皮瘤1例
J Laparoendosc Adv Surg Tech A. 2009 Aug;19(4):505-7. doi: 10.1089/lap.2008.0392.

引用本文的文献

1
Association of anesthesia handovers with perioperative and short-term outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.麻醉交接与细胞减灭术和腹腔热灌注化疗后的围手术期和短期结局的关系。
Surgery. 2024 Nov;176(5):1450-1457. doi: 10.1016/j.surg.2024.07.042. Epub 2024 Aug 27.
2
Intra- and Interpatient Drug Response Heterogeneity Exist in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Nongynecologic Cancers.在接受细胞减灭术和腹腔热灌注化疗治疗非妇科癌症的患者中，存在着内在和个体间的药物反应异质性。
Ann Surg Oncol. 2024 Mar;31(3):1996-2007. doi: 10.1245/s10434-023-14696-6. Epub 2024 Jan 4.
3
Predictors of Financial Toxicity Risk Among Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC).
行细胞减灭术联合腹腔热灌注化疗（CRS-HIPEC）患者的财务毒性风险预测因素。
Ann Surg Oncol. 2024 Mar;31(3):1980-1989. doi: 10.1245/s10434-023-14577-y. Epub 2023 Dec 4.
4
Peritoneal Mesothelioma: Systematic Review of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Protocol Outcomes.腹膜间皮瘤：热灌注化疗（HIPEC）方案疗效的系统评价
Indian J Surg Oncol. 2023 Jun;14(Suppl 1):39-59. doi: 10.1007/s13193-023-01728-6. Epub 2023 Mar 4.
5
Immunotherapy in malignant peritoneal mesothelioma (Review).恶性腹膜间皮瘤的免疫治疗（综述）
Mol Clin Oncol. 2023 Feb 22;18(4):31. doi: 10.3892/mco.2023.2627. eCollection 2023 Apr.
6
Malignant peritoneal mesothelioma literature review: past, present, and future.恶性腹膜间皮瘤文献综述：过去、现在与未来。
Dig Med Res. 2022 Jun;5. doi: 10.21037/dmr-22-19. Epub 2022 Jun 30.
7
The role of imaging in diagnosis and management of malignant peritoneal mesothelioma: a systematic review.影像学在恶性腹膜间皮瘤诊断与管理中的作用：一项系统评价
Abdom Radiol (NY). 2022 May;47(5):1725-1740. doi: 10.1007/s00261-022-03464-x. Epub 2022 Mar 7.
8
Survival Outcomes for Malignant Peritoneal Mesothelioma at Academic Versus Community Hospitals.学术型医院与社区医院中恶性腹膜间皮瘤的生存结果
J Gastrointest Surg. 2022 Jan;26(1):161-170. doi: 10.1007/s11605-021-05084-0. Epub 2021 Jul 21.
9
Peritoneal mesothelioma associated with bladder cancer and occupational exposure to asbestos: A case report.与膀胱癌及职业性石棉暴露相关的腹膜间皮瘤：一例报告
Clin Case Rep. 2020 Nov 4;8(12):3529-3532. doi: 10.1002/ccr3.3465. eCollection 2020 Dec.
10
Repurposing Quinacrine for Treatment of Malignant Mesothelioma: In-Vitro Therapeutic and Mechanistic Evaluation.将奎纳克林重新用于治疗恶性间皮瘤：体外治疗及机制评估
Int J Mol Sci. 2020 Aug 31;21(17):6306. doi: 10.3390/ijms21176306.